Immune Profile and Complication Risk in Type 2 Diabetes (IMPACT)
Primary Purpose
Diabetes Mellitus, Type 2
Status
Unknown status
Phase
Locations
Denmark
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Diabetes Mellitus, Type 2 focused on measuring Diabetes Mellitus, Type 2, Mannose-Binding lectin, Toll-Like Receptors, Atherosclerosis, Carotid Arteries, Diabetes Complications, Diabetic Angiopathies
Eligibility Criteria
Inclusion Criteria:
- Diabetics: Newly diagnosed (<5 years since diagnoses) type 2 diabetes due to national diagnosis criteria
- Controls: No diabetes or prediabetes in oral glucose tolerance test
Both:
- Age > 18 years
- Signed informed consent
Exclusion Criteria:
Both:
- Pacemaker or other magnetic materials in the body
- Severe claustrophobia
- Pregnancy/lactation
- Cancer - former or current
- Acute or chronic infection
- Dialysis-dependent kidney disease
Sites / Locations
- Medical Department M, Aarhus University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Arm Label
Diabetics
Controls
Arm Description
100 patients with newly diagnosed (<5 years since diagnosis) type 2 diabetes referred from general practitioners to Medical Department M, Aarhus University Hospital, Denmark.
100 healthy (no diabetes or prediabetes in oral glucose tolerance test) control subjects matched for age and gender
Outcomes
Primary Outcome Measures
Plaque burden in carotid arteries
Secondary Outcome Measures
Serum levels of pattern recognition molecules
Genotyping genes for pattern recognition molecules
Full Information
NCT ID
NCT00674271
First Posted
May 5, 2008
Last Updated
November 3, 2011
Sponsor
University of Aarhus
Collaborators
Aarhus University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00674271
Brief Title
Immune Profile and Complication Risk in Type 2 Diabetes
Acronym
IMPACT
Official Title
Immune Profile and Complications Risk in Type 2 Diabetes
Study Type
Observational
2. Study Status
Record Verification Date
November 2011
Overall Recruitment Status
Unknown status
Study Start Date
May 2008 (undefined)
Primary Completion Date
March 2011 (Actual)
Study Completion Date
May 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Aarhus
Collaborators
Aarhus University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to investigate the relation between individual differences in pattern recognition molecules (PRM's) in the innate immune system and the prevalence and development of vascular complications in patients with type 2 diabetes.
This is based on the hypothesis that pattern recognition molecules (PRM's) in the innate immune system contributes to a chronic low grade inflammation in diabetic patients. Variation in PRM's - at the genome, proteome as well as the functional level - are therefore associated with the degree of chronic low grade inflammation, and probably also with the prevalence of vascular complications.
Detailed Description
Aim: The primary aims of the project are:
By use of advanced magnetic resonance imaging to characterize the prevalence of atherosclerosis in the carotid arteries in patients with newly diagnosed type 2 diabetes.
To investigate if individual differences in the innate immune system contributes to the prevalence and development of cardiovascular disease in patients with type 2 diabetes.
To prospectively observe the cardiovascular morbidity and mortality in a cohort of patients with type 2 diabetes seen in the light of the obtained baseline characteristics.
Background: Type 2 diabetes is a very common disease in the western world. Patients with type 2 diabetes are at risk of a number of complications, including macroangiopathy which involves an accelerated atherosclerosis, that causes most of the increased mortality and morbidity in type 2 diabetics. Mounting evidence suggests that development of vascular complications is associated to a chronic low grad inflammation in type 2 diabetes. Individual differences in the innate immune system might contribute to this chronic low grade inflammation as it has become apparent that in some situations - as after tissue ischemia or in diabetes - a change in the body's own cell glycosylations occurs, which leads to increased affinity of PRM's. This study will focus primarily on two families of PRM's: Collectins and Toll-like receptors.
Methods: The study consists of a prospective observational cohort study of 100 newly diagnosed type 2 diabetic patients with continuous 2-year clinical follow-up and a register-based follow-up of morbidity and mortality study after 5 and 10 years. Furthermore 100 healthy control subjects will be included. Baseline data will represent a independent cross-sectional study of the relationship between the innate immune system, glycemic control and the presence of atherosclerosis in the carotid arteries in newly diagnosed type 2 diabetic patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
Diabetes Mellitus, Type 2, Mannose-Binding lectin, Toll-Like Receptors, Atherosclerosis, Carotid Arteries, Diabetes Complications, Diabetic Angiopathies
7. Study Design
Enrollment
200 (Anticipated)
Biospecimen Retention
Samples With DNA
Biospecimen Description
Whole blood, urine
8. Arms, Groups, and Interventions
Arm Title
Diabetics
Arm Description
100 patients with newly diagnosed (<5 years since diagnosis) type 2 diabetes referred from general practitioners to Medical Department M, Aarhus University Hospital, Denmark.
Arm Title
Controls
Arm Description
100 healthy (no diabetes or prediabetes in oral glucose tolerance test) control subjects matched for age and gender
Primary Outcome Measure Information:
Title
Plaque burden in carotid arteries
Time Frame
Individual
Secondary Outcome Measure Information:
Title
Serum levels of pattern recognition molecules
Time Frame
Individual
Title
Genotyping genes for pattern recognition molecules
Time Frame
Individual
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Diabetics: Newly diagnosed (<5 years since diagnoses) type 2 diabetes due to national diagnosis criteria
Controls: No diabetes or prediabetes in oral glucose tolerance test
Both:
Age > 18 years
Signed informed consent
Exclusion Criteria:
Both:
Pacemaker or other magnetic materials in the body
Severe claustrophobia
Pregnancy/lactation
Cancer - former or current
Acute or chronic infection
Dialysis-dependent kidney disease
Study Population Description
100 patients with newly diagnosed (<5 years since diagnosis) type 2 diabetes referred from general practitioners to Medical Department M, Aarhus University Hospital, Denmark.
100 healthy (no diabetes or prediabetes in oral glucose tolerance test) control subjects matched for age and gender.
Sampling Method
Non-Probability Sample
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jens S Christiansen, Prof., MD
Organizational Affiliation
Medical Department M, Aarhus University Hospital, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Medical Department M, Aarhus University Hospital
City
Aarhus C
ZIP/Postal Code
8000
Country
Denmark
12. IPD Sharing Statement
Citations:
PubMed Identifier
27405963
Citation
Laugesen E, Hoyem P, Fleischer J, Kumarathas I, Knudsen ST, Hansen KW, Christiansen JS, Hansen TK, Poulsen PL. Reduced Subendocardial Viability Ratio Is Associated With Unfavorable Cardiovascular Risk Profile in Women With Short Duration of Type 2 Diabetes. Am J Hypertens. 2016 Oct;29(10):1165-72. doi: 10.1093/ajh/hpw066. Epub 2016 Jul 12.
Results Reference
derived
PubMed Identifier
26714500
Citation
Funck KL, Laugesen E, Hoyem P, Fleischer J, Cichosz SL, Christiansen JS, Hansen TK, Poulsen PL. Low Physical Activity Is Associated With Increased Arterial Stiffness in Patients Recently Diagnosed With Type 2 Diabetes. Am J Hypertens. 2016 Jul;29(7):882-8. doi: 10.1093/ajh/hpv197. Epub 2015 Dec 28.
Results Reference
derived
PubMed Identifier
25573884
Citation
Fleischer J, Lebech Cichosz S, Hoeyem P, Laugesen E, Loegstrup Poulsen P, Sandahl Christiansen J, Tarnow L, Hansen TK. Glycemic variability is associated with reduced cardiac autonomic modulation in women with type 2 diabetes. Diabetes Care. 2015 Apr;38(4):682-8. doi: 10.2337/dc14-0654. Epub 2015 Jan 8. Erratum In: Diabetes Care. 2015 Nov;38(11):2188.
Results Reference
derived
PubMed Identifier
23866070
Citation
Laugesen E, Hoyem P, Christiansen JS, Knudsen ST, Hansen KW, Argraves WS, Hansen TK, Poulsen PL, Rasmussen LM. Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study. Cardiovasc Diabetol. 2013 Jul 18;12:107. doi: 10.1186/1475-2840-12-107.
Results Reference
derived
PubMed Identifier
23129135
Citation
Laugesen E, Hoyem P, Stausbol-Gron B, Mikkelsen A, Thrysoe S, Erlandsen M, Christiansen JS, Knudsen ST, Hansen KW, Kim WY, Hansen TK, Poulsen PL. Carotid-femoral pulse wave velocity is associated with cerebral white matter lesions in type 2 diabetes. Diabetes Care. 2013 Mar;36(3):722-8. doi: 10.2337/dc12-0942. Epub 2012 Nov 5.
Results Reference
derived
Learn more about this trial
Immune Profile and Complication Risk in Type 2 Diabetes
We'll reach out to this number within 24 hrs